We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+38.1%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$3.04B
AUM Growth
+$491M
Cap. Flow
-$7.19M
Cap. Flow %
-0.24%
Top 10 Hldgs %
51.04%
Holding
476
New
28
Increased
115
Reduced
198
Closed
20

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$9.08M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.02M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$8.99M
4
UBER icon
Uber
UBER
+$6.62M
5
NVDA icon
NVIDIA
NVDA
+$3.91M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$21.7M
2
GS icon
Goldman Sachs
GS
+$11M
3
EBAY icon
eBay
EBAY
+$8.22M
4
ALTM
Arcadium Lithium plc
ALTM
+$5.15M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.65M

Sector Composition

Rank Sector Weight
1 Healthcare 36.79%
2 Energy 11.75%
3 Technology 11.43%
4 Financials 10.93%
5 Industrials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB icon
26
Chubb
CB
$141B
$22.6M 0.74%
74,912
+1,966
+3% +$546K
GL icon
27
Globe Life
GL
$13.9B
$21.7M 0.71%
164,571
– –
MRK icon
28
Merck
MRK
$326B
$21.1M 0.69%
234,673
-6,712
-3% -$627K
HXL icon
29
Hexcel
HXL
$8.3B
$20.8M 0.68%
379,472
-10,574
-3% -$661K
UL icon
30
Unilever
UL
$144B
$19.5M 0.64%
291,568
-30,902
-10% -$1.99M
C icon
31
Citigroup
C
$222B
$18.9M 0.62%
265,747
-21,647
-8% -$1.65M
CPRT icon
32
Copart
CPRT
$28.4B
$17.4M 0.57%
307,924
-798
-0.3% -$44.9K
PFE icon
33
Pfizer
PFE
$144B
$16.3M 0.54%
644,920
+2,815
+0.4% +$73.7K
TTE icon
34
TotalEnergies
TTE
$187B
$16.3M 0.54%
252,424
+63,564
+34% +$3.83M
STRS icon
35
Stratus Properties
STRS
$156M
$15.9M 0.52%
895,201
-300
-0% -$5.69K
TECK icon
36
Teck Resources
TECK
$28.8B
$15.1M 0.5%
415,095
-11,700
-3% -$485K
KVUE icon
37
Kenvue
KVUE
$37.9B
$15M 0.49%
627,351
-84,329
-12% -$1.87M
MDLZ icon
38
Mondelez International
MDLZ
$80.2B
$15M 0.49%
220,731
+147,320
+201% +$9.08M
JNJ icon
39
Johnson & Johnson
JNJ
$643B
$14.3M 0.47%
86,133
-3,950
-4% -$618K
MCO icon
40
Moody's
MCO
$83.9B
$14.2M 0.47%
30,489
-197
-0.6% -$94.9K
NVS icon
41
Novartis
NVS
$304B
$14.1M 0.46%
126,248
+9,247
+8% +$984K
CACC icon
42
Credit Acceptance
CACC
$5.84B
$13.2M 0.43%
25,608
-51
-0.2% -$25.2K
NSC icon
43
Norfolk Southern
NSC
$76.1B
$12.3M 0.41%
51,986
+339
+0.7% +$82.6K
VOO icon
44
Vanguard S&P 500 ETF
VOO
$971B
$11.5M 0.38%
22,452
+16,634
+286% +$8.99M
WSM icon
45
Williams-Sonoma
WSM
$27.8B
$10.8M 0.36%
68,566
-475
-0.7% -$91.8K
UNP icon
46
Union Pacific
UNP
$175B
$10.4M 0.34%
43,989
-6,521
-13% -$1.57M
BRK.A icon
47
Berkshire Hathaway Class A
BRK.A
$1.1T
$10.4M 0.34%
13
– –
FCX icon
48
Freeport-McMoran
FCX
$88.6B
$10.3M 0.34%
271,432
+16,558
+6% +$634K
PEP icon
49
PepsiCo
PEP
$195B
$10.2M 0.34%
68,311
-122
-0.2% -$18.2K
JCI icon
50
Johnson Controls International
JCI
$85.6B
$10.2M 0.34%
127,533
-24,262
-16% -$1.99M
1
2
3 4 5

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return

Ingalls & Snyder LLC's Q1 2025 Portfolio in Review

As of Q1 2025, Ingalls & Snyder LLC held 476 positions worth $3.04B, up 19% from $2.55B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Ingalls & Snyder LLC's Q1 2025 filing shows 28 new, 115 increased, 198 reduced and 20 closed positions. Its largest new stake was Orion: 270,493 shares worth $3.5M. The largest sale was Corcept Therapeutics, an estimated $21.7M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 25% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2025 buy was Orion: 270,493 shares worth $3.5M.
  • Ingalls & Snyder LLC added most to Mondelez International in Q1 2025, an estimated $9.08M increase.
  • Ingalls & Snyder LLC's biggest Q1 2025 reduction was Corcept Therapeutics, cutting an estimated $21.7M.
  • Ingalls & Snyder LLC fully exited Arcadium Lithium plc in Q1 2025, selling an estimated $5.15M.
  • Ingalls & Snyder LLC's ten largest holdings make up 51% of its $3.04B portfolio in Q1 2025.
  • Ingalls & Snyder LLC opened 28 new positions and closed 20 in Q1 2025.
  • Ingalls & Snyder LLC's portfolio value rose 19% quarter-over-quarter to $3.04B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2025, filed 12 May 2025.